2016 Fiscal Year Final Research Report
Development of water-soluble Zinc porphyrin aimed at Theranostics
| Project/Area Number |
26410189
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Bio-related chemistry
|
|---|
| Research Institution | Ube National College of Technology |
|---|
Principal Investigator |
HIROHARA SHIHO 宇部工業高等専門学校, 物質工学科, 教授 (70413804)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
OBATA Makoto 山梨大学, 総合研究部, 准教授 (70343267)
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Keywords | ポルフィリン亜鉛錯体 / がん診断法(PET) / がん治療法(PDT) / グルコース鎖 / メルカプトエタノール鎖 / Theranostics |
|---|
| Outline of Final Research Achievements |
We synthesized [65Zn] or [Zn]-5,10,15,20-tetrakis(pentafluorophenyl)porphyrins ([65Zn]-P or Zn-P) bearing two kinds of substituent groups (G2M2), namely glucose group (denoted as G) and 2-mercaptoethanol group (denoted as M) as theranostics drug. The in vitro photocytotoxicity of Zn-PG2M2 was evaluated in HeLa human cervical cell line, RGK gastric carcinoma mucosal cell line, and two human glioblastoma cell lines (U87 and T98G). Zn-PG2M2 exerted the higher photocytotoxicity than fully glucosylated TFPP (G4) at 8 h incubation. From the pharmacokinetics study, the accumulation rate of [65Zn]-PG2M2 in the tumor was about the same as that in digestive organs at 24 h after intraperitoneal injection.
|
| Free Research Field |
生体関連
|
